Launching the Sino-Korean Clinical Research Center System

In-depth Research on Sino-Korean Medical Technology x Product R&D Source

DNA SKIN HARMONY

Third Stop: Guangdong & Shenzhen Region

On July 25, 2024, the third stop of this source visit to Korea group will be in the Guangdong, Shenzhen, and Hainan regions. This event gathers experts and scholars from both China and Korea, aiming to promote in-depth exchanges and cooperation between the two countries in product R&D and practical technology dimensions. Through on-site visits and clinical discussions, we will advance the improvement of the Sino-Korean Clinical Research Center system.

A New Chapter in Sino-Korean Cooperation: Deepening Technical Exchanges and Cooperation in the Medical Aesthetics Field

In the context of accelerating globalization, international cooperation has become a key driving force for development across various industries. In the medical aesthetics industry, China and Korea are joining hands to enter a new era, leveraging their respective technological advantages and rich clinical experiences. Cooperation between the two countries can achieve resource sharing and complementary advantages, resulting in a win-win situation across multiple dimensions such as technology R&D, product innovation, and clinical practice, further promoting the development of the medical aesthetics industry.

R&D Center Source Visit: Driving the DOT Specialized Technology Innovation Engine

Through this visit to Korea's top medical aesthetics R&D center, experts and scholars gained a deeper understanding of Korea's latest technological achievements in minimally invasive treatments and regenerative medicine. Scientific research and innovative R&D are the core driving forces of the medical aesthetics industry. The R&D center gathers international experts and researchers, focusing on full-chain innovation from basic research to clinical application. Through multi-dimensional and multi-level research, we delve into skin structure and the needs for skin rejuvenation, contributing to revolutionary advancements in medical aesthetics technology.

Compared to traditional technologies, the core advantages of DOT specialized technology lie in precision and controllability. The core component of DCELL / D+JU PN is extracted from the pre-processed salmon frozen testicles using DOT specialized technology. The extracted raw materials undergo processes such as crushing, drying, and packaging, ultimately producing a white powdered high-purity molecular substance of specific specifications.

In-depth Exchange at MAYLIN CLINIC: Strategic Layout in Medical Aesthetics Technology R&D and Clinical Application

In the wave of globalization, the medical aesthetics industry is experiencing unprecedented development opportunities. MAYLIN CLINIC has been committed to promoting academic exchanges and cooperation internationally, driving collaboration between China and Korea in the medical aesthetics field through technology sharing and experience exchange.

Korea enjoys a prestigious reputation internationally due to its advanced medical aesthetics technology and rich clinical experience, while the Chinese market has enormous demand and development potential. Director Park Hyun-jun shared the latest technological achievements of PN/PDRN in the field of skin rejuvenation during the meeting, providing innovative solutions for various skin issues by combining advanced skincare concepts with clinical experience, offering a new perspective on delaying skin aging.

Institutional Project Strategic Integration: Building an Ecological Closed Loop in the Medical Aesthetics Industry

Driven by both technology and market forces, China and Korea are jointly promoting the strategic integration of institutional projects, aiming to build a comprehensive medical aesthetics ecosystem. From product sourcing, technological innovation to market promotion, every link is integrated and innovated collaboratively to respond quickly to market demands, launching products and services that better meet the personalized expectations of beauty seekers. In the future, we aim to create an ecological closed loop with high flexibility and adaptability, maximizing core competitiveness.

Demonstration of Dual Di Combined Therapy: A Benchmark for Precision Personalized Treatment

During the meeting, Director Park provided a systematic training platform for physicians, helping them master the latest medical aesthetics technologies and improve clinical outcomes, thus providing higher quality beauty services. Through real case analyses, different treatment options and procedures were showcased, and practical demonstrations helped physicians learn how to perform precise operations in clinical settings. The precision of the dual Di combined therapy in personalized diagnosis and assessment was affirmed, combining theory with practice, supported by scientific data and rich clinical experience, tailoring exclusive beauty plans for each beauty seeker.

Sino-Korean Joint Technical Innovation: Promoting the Improvement of the Sino-Korean Clinical Research Center System

Through the construction of the Sino-Korean Clinical Research Center, Dual Di will collaborate with more industry opinion leaders to enhance international influence and academic standards. We firmly believe that Sino-Korean cooperation will bring more innovation and possibilities for the global medical aesthetics industry, and we look forward to working hand in hand in the future to jointly create a new chapter in the medical aesthetics industry.